Home Sarepta Therapeutics Announces Plans To Submit Rolling NDA For Eteplirsen Following Today's Pre-NDA Meeting With The FDA
 

Keywords :   


Sarepta Therapeutics Announces Plans To Submit Rolling NDA For Eteplirsen Following Today's Pre-NDA Meeting With The FDA

2015-06-03 06:47:48| drugdiscoveryonline Home Page

Sarepta Therapeutics, Inc., a developer of innovative RNA-targeted therapeutics, recently announced that the Company held a pre-New Drug Application (NDA) meeting with the U.S

Tags: the with submit plans

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Eastern North Pacific Tropical Weather Outlook
05.10Atlantic Tropical Weather Outlook
04.10Should you tip even if the service wasn't worth it?
04.10Hurricane Kirk Graphics
04.10Hurricane Kirk Forecast Discussion Number 22
04.10Tropical Storm Leslie Forecast Discussion Number 10
04.10Hurricane Kirk Wind Speed Probabilities Number 22
04.10Hurricane Kirk Public Advisory Number 22
More »